Senate LDA lobbying filing
CARDINAL HEALTH INC
Reported income
not reported
Reported expenses
$1.32M
Tracked program mentions1
Quoted activity text is clipped to a short extract; each filing’s full description is under Lobbying activities below.
- Making, Maintaining, Supply Chain and Logistics0602025Ematched: “Supply|Chain”matched 2+ title words
Education on supply chain issues, drug shortages, domestic manufacturing, medical device environmental issues; Issues…
Lobbying activities4
Health IssuesHCR
Issues related to drug pricing, bona fide service fees, pharmacies, provider status, biosimilars, cell and gene therapy, food is medicine; Issues related to provider reimbursement, Medicare and Medicaid, workforce shortages, and product shortages; Issues related to Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS), competitive bidding, reimbursement to home health agencies, and acute hospital care at home services; H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act; H.R. 5031/S. 3159, Preserving Patient Access to Long-Term Care Pharmacies Act; H.R. 3164/S. 2426, Ensuring Community Access to Pharmacist Services Act; Education around issues facing independent physicians, including S.3822, the Break Up Big Medicine Act.
ManufacturingMAN
Education on supply chain issues, drug shortages, domestic manufacturing, medical device environmental issues; Issues related to the medical supply chain and transportation.
Tariff (miscellaneous tariff bills)TAR
Issues related to tariffs, trade, and U.S. trade policy.
Trade (domestic/foreign)TRD
Issues related to tariffs, trade, and U.S. trade policy.
Lobbyists4
- ABIGAIL BARNES
- ANGELEINE COMTE
- JERRICA MATHIS
- REBECCA MCGRATH
Source: U.S. Senate Lobbying Disclosure Act database. Dollar figures (underlined) cite the filing record on lda.senate.gov — click to view the citation. Amounts shown as “not reported” are absent from the filing itself.